v3.26.3
Leases (Tables)
 9 Months Ended
Sep. 30, 2026
Leases [Abstract]  
Schedule of Lease, Cost The components of the Company’s lease expense are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Operating lease expense$4,596 $4,316 $13,110 $12,326 
Short-term lease expense280 159 728 443 
Supplemental cash flow information related to the Company’s leases is as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$4,691 $4,288 $12,983 $12,133 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities2,164 1,475 26,140 11,957 
Supplemental balance sheet information related to the Company’s leases is as follows:
September 30,
2026		December 31,
2025
Right-of-use lease assets$51,256 $38,737 
Other accrued liabilities12,317 12,536 
Long-term lease liabilities35,494 22,759 
Total operating lease liabilities$47,811 $35,295 
Weighted average remaining lease term (years)9.15.7
Weighted average discount rate6.69 %6.58 %
Schedule of Lessee, Operating Lease, Liability, Maturity
Maturities of operating lease liabilities as of September 30, 2026 were as follows:
For the remainder of 2026$4,814 
For the year ended December 31, 202713,454 
For the year ended December 31, 20289,057 
For the year ended December 31, 20295,693 
For the year ended December 31, 20303,551 
For the year ended December 31, 2031 and beyond29,893 
  Total lease payments66,462 
    Less: imputed interest(18,651)
Present value of lease liabilities (1)
$47,811 
(1) During the year ended December 31, 2024, the Company entered into a new lease agreement for office and laboratory space in Radnor, Pennsylvania for the purpose of relocating its global headquarters. The lease for one portion of the laboratory space commenced during the second quarter of 2026 with a present value of operating lease liabilities of $19.8 million as of the lease commencement date. The lease for the remaining portions of laboratory and office space is expected to commence upon the completion of the lessor-owned leasehold improvements, which is expected to be in the fourth quarter of 2026. The cumulative future lease commitment for the remaining laboratory and office space that has not yet commenced is $48.8 million. The future lease commitments relating to the leases that have not yet commenced were not included in the operating lease liabilities balance as of September 30, 2026.